14.21
-0.03
(-0.21%)
At close: January 30 at 4:00:01 PM EST
14.39
+0.18
+(1.27%)
After hours: January 30 at 4:34:40 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 694.81k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| GOLDAN KEITH ALAN Chief Financial Officer | Purchase at price 20.03 per share. | Direct | 25,037 | Jun 14, 2024 |
| PODLESAK DENNIS G Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 7, 2024 |
| KATKIN KEITH A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 7, 2024 |
| LEGAULT PIERRE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 7, 2024 |
| GOLDAN KEITH ALAN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 7, 2024 |
| METZGER MICHAEL A Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 7, 2024 |
| MEURY WILLIAM Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 7, 2024 |
| MORRISON BRIGGS W. M.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 7, 2024 |
| HUBER MARTIN H JR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 7, 2024 |
| JARRETT A JENNIFER Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 7, 2024 |
| GALLAGHER NEIL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 7, 2024 |
| MORRISON BRIGGS W. M.D. Director | Sale at price 18.27 per share. | Direct | 965,402 | Aug 9, 2023 |
| MORRISON BRIGGS W. M.D. Director | Conversion of Exercise of derivative security at price 8.77 per share. | Direct | 463,538 | Aug 9, 2023 |
| MEURY WILLIAM Director | Sale at price 20.45 - 20.46 per share. | Direct | 1,697,810 | Aug 2, 2023 |
| MEURY WILLIAM Director | Conversion of Exercise of derivative security at price 7.11 - 9.47 per share. | Direct | 665,250 | Aug 2, 2023 |
| MORRISON BRIGGS W. M.D. Director | Sale at price 20.40 per share. | Direct | 1,078,068 | Jul 10, 2023 |
| MORRISON BRIGGS W. M.D. Director | Conversion of Exercise of derivative security at price 8.77 per share. | Direct | 463,538 | Jul 10, 2023 |
| GOLDAN KEITH ALAN Chief Financial Officer | Sale at price 22.31 per share. | Direct | 12,873 | Jun 13, 2023 |
| MORRISON BRIGGS W. M.D. Director | Sale at price 21.18 per share. | Direct | 1,119,421 | Jun 9, 2023 |
| MORRISON BRIGGS W. M.D. Director | Conversion of Exercise of derivative security at price 6.38 - 8.77 per share. | Direct | 404,787 | Jun 9, 2023 |
| MORRISON BRIGGS W. M.D. Director | Sale at price 21.41 per share. | Direct | 1,131,478 | May 9, 2023 |
| MORRISON BRIGGS W. M.D. Director | Conversion of Exercise of derivative security at price 6.38 per share. | Direct | 337,215 | May 9, 2023 |
| MORRISON BRIGGS W. M.D. Director | Sale at price 19.53 per share. | Direct | 1,032,237 | Apr 10, 2023 |
| MORRISON BRIGGS W. M.D. Director | Conversion of Exercise of derivative security at price 6.38 per share. | Direct | 337,215 | Apr 10, 2023 |
| MORRISON BRIGGS W. M.D. President | Sale at price 22.53 per share. | Direct | 1,190,674 | Mar 13, 2023 |
| MORRISON BRIGGS W. M.D. President | Conversion of Exercise of derivative security at price 6.38 per share. | Direct | 337,209 | Mar 13, 2023 |
| ORDENTLICH PETER Officer | Sale at price 25.84 per share. | Direct | 646,092 | Feb 15, 2023 |
| ORDENTLICH PETER Officer | Conversion of Exercise of derivative security at price 6.38 - 7.20 per share. | Direct | 173,791 | Feb 15, 2023 |
| MORRISON BRIGGS W. M.D. Officer and Director | Sale at price 26.83 per share. | Direct | 1,417,909 | Feb 6, 2023 |
| METZGER MICHAEL A Chief Executive Officer | Sale at price 27.64 per share. | Direct | 164,697 | Feb 6, 2023 |
| METZGER MICHAEL A Chief Executive Officer | Conversion of Exercise of derivative security at price 6.38 per share. | Direct | 38,018 | Feb 6, 2023 |
| MORRISON BRIGGS W. M.D. Officer and Director | Conversion of Exercise of derivative security at price 6.38 per share. | Direct | 337,209 | Feb 6, 2023 |
| PODLESAK DENNIS G Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 2, 2023 |
| KATKIN KEITH A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 2, 2023 |
| LEGAULT PIERRE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 2, 2023 |
| MEURY WILLIAM Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 2, 2023 |
| HUBER MARTIN H JR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 2, 2023 |
| JARRETT A JENNIFER Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 2, 2023 |
| ORDENTLICH PETER Officer | Sale at price 28.43 per share. | Direct | 1,962 | Feb 1, 2023 |
Related Tickers
KURA Kura Oncology, Inc.
8.03
+4.42%
CRNX Crinetics Pharmaceuticals, Inc.
40.26
+2.23%
MRUS Merus N.V.
41.57
-0.19%
PTGX Protagonist Therapeutics, Inc.
39.12
+2.38%
EWTX Edgewise Therapeutics, Inc.
28.00
-1.48%
INCY Incyte Corporation
73.77
+0.07%
MLTX MoonLake Immunotherapeutics
47.12
+2.30%
SWTX SpringWorks Therapeutics, Inc.
37.23
+1.94%
KYMR Kymera Therapeutics, Inc.
40.45
+2.66%
AGIO Agios Pharmaceuticals, Inc.
34.54
+2.40%